Understanding immune responses to influenza vaccination in health care workers
Official title: Immune Responses to Influenza Vaccinations and Viruses Among Health Care Personnel
Run by Finnish Institute for Health and Welfare · NCT03323112 · Data updated 2026-11-12
This study looks at how the flu vaccine affects the immune system of health care workers over ten years to see how well it protects them from the virus.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Finnish Institute for Health and Welfare Government |
| Locations | 1 site (Helsinki) |
| Status | Recruiting |
| Started | October 18, 2017 |
| Main results expected | October 14, 2027 |
| Study ends | October 14, 2027 |
| Registry record updated | August 20, 2025 |
| Trial ID | NCT03323112 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include health care or laboratory personnel in good health who choose to receive the seasonal influenza vaccination.
✕Probably not a fit
Patients with immunosuppressive conditions, pregnancy, or contraindications for influenza vaccination may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance knowledge about the immune responses elicited by influenza vaccination among health care personnel over a 10-year period. Participants will receive the seasonal influenza vaccine as per routine occupational health care practices, with blood samples collected before vaccination, five weeks after, and six months post-vaccination. The study will analyze both humoral and cellular immunity, the effects of repeated vaccinations, and factors influencing immunological responses. The analysis will primarily be descriptive, focusing on the duration of protection and immunity against circulating viruses.
Why it matters
Potential benefit: If successful, this study could lead to improved vaccination strategies and enhanced protection against influenza for health care workers.
How similar studies have gone: Other studies have explored immune responses to vaccinations, but this specific long-term observational approach focusing on health care workers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Members of health care or laboratory personnel in HUS having decided to take the seasonal influenza vaccination by the routine occupational health care service * General good health as established by or volunteer's own statement * Written informed consent * Presumably able and willing to participate in the study during the starting influenza season Exclusion Criteria: * Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection. * Administration (longer than 14 days) of immunosuppressants or other immune- modifying drugs within 6 months before the vaccination; oral corticosteroids in dosages of 20 mg/day or more prednisolone or equivalent are excluded; inhaled or topical steroids are allowed. * Pregnancy or lactation * Acute disease at the time of enrolment (defined as the presence of a moderate or severe illness with or without fever) * Contraindication for influenza vaccination * Any other criteria which, in the investigator's or dedicated study staff member's opinion, would compromise the ability of a subject to participate in the study, a subject's well-being, or the outcome of the study
Where it's running
-
The Hospital District of Helsinki and Uusimaa
Helsinki, Finland Recruiting
Study contacts
- Principal investigator: Hanna Nohynek, MD, PhD — Finnish Institute for Health and Welfare
- Study coordinator: Hanna Nohynek, MD, PhD
- Email: hanna.nohynek@thl.fi
- Phone: +358 29 524 8246
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy
This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.
-
Abbott ID NOW at the point of care for flu-like illness in long-term care facilities
This trial tests whether the Abbott ID NOW rapid test at the point of care in long-term care facilities can help identify influenza sooner for residents 65 and older with fever and respiratory symptoms.
-
Egg-based H5N8 influenza vaccine at multiple doses with or without adjuvant in healthy adults
This trial tests whether an egg-based H5N8 flu vaccine, given at low to high doses with or without an adjuvant, is safe and can provoke a stronger immune response in healthy adults 18 and older.
-
Safety and PK of Ingavirin Forte vs Ingavirin in healthy adults under fasting and fed conditions
This early-phase study tests whether Ingavirin Forte (90 mg + 20 mg) is safe and how it behaves in the body compared with Ingavirin (90 mg) in healthy adults aged 18–45, under different meal conditions.
-
Light-based immune boost to help prevent viral upper respiratory infections
A daily handheld light therapy device is tested to see if it can lower how often adults at a military medical facility get colds, flu, or other upper respiratory infections.
-
Virological Monitoring of Seasonal Respiratory Infections in France
This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.